KONICA-MINOLTA
Konica Minolta, Inc. (Konica Minolta) (TOKYO:4902) (ISIN:JP3300600008) will launch at the end of 2015 the Nassenger SP-1, a high-productivity, high-resolution inkjet textile printer that employs a single path system, in response to the increasing use of digital printing in the textile printing industry. Prior to the launch of this new model, Konica Minolta will give demonstrations of Nassenger SP-1 to customers at its sales subsidiary in Italy, starting from September 2015, and then showcase this model’s technology at ITMA 2015, an international textile machinery exhibition held in Milan, Italy in November 2015.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150811005475/en/
Nassenger SP-1 is characterized by advanced features such as ultra-high speed, high productivity and high resolution, which are made possible by Konica Minolta’s expertise in developing and producing all printheads, printing mechanisms and inks for inkjet textile printers.
Main features
- Nassenger SP-1 employs a single path system that prints on a fabric (or other print medium) as the fabric is fed under a fixed print unit. This model boasts a much higher print speed than a scan-type printer that prints by moving a printhead carriage back and forth, and thus can meet the needs of the market for a printer with the speed of a screen printing machine.
- The highly precise ink ejection control capability of this model enables high-resolution images to be reproduced at an ultra-high speed.
- The model incorporates a newly developed printheads that can eject smaller ink droplets than conventional printers and Konica Minolta’s proprietary ink ejection control technology, which enables the ink droplet size to be adjusted (large, medium, and small), thus achieving higher-quality reproduction of fine patterns and color gradients.
-
The model employs the following mechanisms that help to reduce
downtime that can directly affect productivity:
- Konica Minolta’s proprietary image processing technology minimizes the problems of streaking and uneven density on a printed image and reduces defective prints.
- The modular printhead and the capability of automatic adjustment of ink droplet ejection positions enable far faster exchanging of printheads. - Reactive dye ink*1 and disperse ink*2 developed specifically for the single-path system can be used. The reactive ink meets the criteria of the Global Organic Textile Standard (GOTS)*3 .
Background to the development
In the global textile market, there have been increasing demands for low-volume high-mix production, shorter lead time, improved print quality, resource saving and environmental preservation. Against this backdrop, inkjet textile printing is gaining popularity among customers for the unique capabilities of digital printing that can cater to all these demands, namely: (1) on-demand printing, (2) plateless printing, and (3) greater environment friendliness resulting from the reduction of effluent and use of fuels.
While screen printing machines with print speeds of 2000-3000 m2 /hour are used for high-volume printing in most cases, users of these machines are now calling for inkjet textile printers with the print speed of screen printing machines. Nassenger SP-1 was developed to meet the needs of these users.
*Demonstration of Nassenger SP-1
Konica Minolta will set up a
demonstration room in Konica Minolta IJ Textile Europe, a sales
subsidiary established in Como, Milan, the center of the textile
printing industry in Europe, to give demonstrations of Nassenger SP-1
for prospective customers starting from September 2015.
*ITMA 2015
ITMA is the largest textile machinery exhibition in the
world, held every four years. ITMA 2015 will be held from November 12 to
19 in Fiera Milan (Rho), where Konica Minolta will showcase the
technology of Nassenger SP-1 at its booth C108 in Hall 18.
With its brand proposition “Giving Shape to Ideas,” Konica Minolta remains committed to innovations in the manufacturing process in the textile printing market, and to helping customers enhance their corporate value, while joining the global effort to reduce environmental threats.
*1: This ink is most suitable for fabrics made of plant fibers such as
cotton and rayon.
*2: This ink is most suitable for fabrics made of
artificial fibers such as polyester.
*3: GOTS is a global standard
for textiles made from organic fibers, and regulates the chemicals used
throughout the production process from raw cotton to finished products.
The GOTS certification is given to products and dyes that meet
comprehensive criteria, both environmental and social, set by GOTS.
For more information,
http://www.konicaminolta.com/inkjet/
View source version on businesswire.com: http://www.businesswire.com/news/home/20150811005475/en/
Contact:
Konica Minolta, Inc.
Akihisa Maruyama, +81-42-589-3702
Inkjet
Business Unit
textile-support@pub.konicaminolta.jp
http://www.konicaminolta.com/inkjet/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum